2021 Outlook on FDA Submissions

---

DEVICE L❤️VE Live! is a biweekly and interactive live show featuring expert panelists discussing timely topics, challenges, and solutions in the medical device and diagnostics industries. The panelists also answer audience questions. Every episode is added to our podcast, too.

---

RQM+_Device_Love_Live_27-min

We’re almost one month into 2021... and we're sure everyone's hoping for a much better year than the last! With a focus on FDA regulatory submissions, we would like to provide context for what occurred in 2020 and provide forward-looking guidance for expectations in 2021.

Will 2021 be smooth sailing or is turbulence ahead? Our panel of esteemed regulatory experts, including former FDA CDRH representatives, will discuss their thoughts on FDA focus areas, new guidance documents, and requirements on the way, along with the continued impact of COVID-19 on FDA resources and submission timelines.

Please bring your questions and join the discussion live!

  • Nancy Morrison - Executive Director of Regulatory and Quality Consulting Services

  • Kevin Go - Senior Engineer (former FDA CDRH Lead Reviewer)

  • Bryan Pinder - Project Engineer (former FDA CDRH Lead Reviewer)

  • Jessica Czamanski - Project Engineer

 

"Proin gravida nibh vel velit auctor aluquet. Aenean sollicitudin, lorem quis bibendum auctor, nisi elit consequat ipsum, nec sagittis vulputate cursus a sit amet."

Joe Smith - President & CEO of Smith Corp.